ArticleTransplantation proceedings2013
Posttransplantation systemic immunomodulation with SA-FasL-engineered donor splenocytes has robust efficacy in preventing cardiac allograft rejection in mice.
H Zhao et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.